JCRB0156 KHYG-1
Cell information
Important Notice(s)JCRB0156 KHYG-1: Tips of cultivation
CD25 expression in KHYG-1 cells
Cell type:general cells (View Pricing Information)
JCRB No. | JCRB0156 | Cell Name | KHYG-1 |
---|---|---|---|
Profile | Human natural killer cell line with a p53 point mutation as a model for p53-associated leukemogenesis and a model for differentiation of NK/T cells. | Other Name | KHYG |
Animal | human | Strain | |
Genus | Homo | Species | sapiens |
Sex | F | Age | 45 |
Identity | Tissue for Primary Cancer | hemo-lymphocytic | |
Case history | aggressive NK cell leukemia | Metastasis | No |
Tissue Metastasized | Genetics | p53 point mutation | |
Life Span | infinite | Crisis PDL | |
Morphology | lymphocyte-like | Character | high NK/LAK activity, IFN gamma production etc. |
Classify | tumor | Established by | Yagita,M. |
Registered by | Yagita,M. | Regulation for Distribution | not defined |
Comment | Year | 2000 | |
Medium | RPMI1640 medium containing with 10% fetal calf serum and 100 units/ml of rIL-2(Shionogi). | Methods for Passages | Simple dilution because of suspension cell culture. Subculture every 3-4 days with split ratio = 1/4. |
Cell Number on Passage | Split 1/4 every 3-4 days. | Race | Jpanese |
CO2 Conc. | 5 % | Tissue Sampling | peripheral blood |
Tissue Type |
Detection of virus genome fragment by Real-time PCR | |||||||||
---|---|---|---|---|---|---|---|---|---|
Detected DNA Virus | tested | Detected RNA Virus | tested | ||||||
CMV | - | parvoB19 | - | HCV | - | HTLV-1 | - | ||
EBV | - | HBV | - | HIV-1 | - | HTLV-2 | - | ||
HHV6 | - | HTLV-1 | - | HIV-2 | - | HAV | - | ||
HHV7 | - | HTLV-2 | - |
-/negative. +/positive. nt/not tested. (positive (+) does not immediately mean the production of infectious viral particles.) |
|||||
BKV | - | HIV-1 | - | ||||||
JCV | - | HIV-2 | - | ||||||
ADV | - | HPV18 | - | ||||||
Notes |
Reference | |
---|---|
Pubmed id:10803526 | A novel natural killer cell line (KHYG-1) from a patient with aggressive natural killer cell leukemia carrying a p53 point mutation. Yagita M,Huang CL,Umehara H,Matsuo Y,Tabata R,Miyake M,Konaka Y,Takatsuki K Leukemia. 2000 May;14(5):922-30 |
Images |
---|
LOT Information
Cell No. | JCRB0156 | Cell Name | KHYG-1 |
---|---|---|---|
LOT No. | 11012010 | Lot Specification | distribution |
Medium | RPMI1640 medium with 10% heat-inactivated fetal bovine serum (FBS; GIBCO Cat.# 10099) and 100 units/ml recombinant human IL-2 (Pepro Tech; Cat. # 200-02) | Temperature | 37 C |
Cell Density at Seeding | approx. 5 x 10^5 cells/mL | Methods for Passages | Dilution. Avoid excessive dilution. |
Doubling Time | approx. 54 hrs. | Cell Number in Vial (cells/1ml) | 1.2 x 10^6 |
Viability at cell freezing (%) | 88.1 | Antibiotics Used | free |
Passage Number | Unknown (9 at bank) | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | Confirmed as human by NP, G6PD (type B), MD. |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | No | Exoteric Gene | |
Medium for Freezing | 10% DMSO, 20% FBS - RPMI1640 | CO2 Conc. | 5% |
Viability immediately after thawing (%) | Additional information |
Cell No. | JCRB0156 | Cell Name | |
---|---|---|---|
LOT No. | 07242006 | Lot Specification | distribution |
Medium | RPMI1640 medium with 10% fetal bovine serum and 100 units/ml IL-2 (corresponds to 50 ng/ml IL-2 Wako#097-03951) (FBS lot; GIBCO 4218333S) | Temperature | 37 C |
Cell Density at Seeding | 2 - 5 x 10^5 cells/ml | Methods for Passages | dilution (avoid excessive dilution) |
Doubling Time | approx. 30 hrs | Cell Number in Vial (cells/1ml) | 1.6 x 10^6 |
Viability at cell freezing (%) | 89 | Antibiotics Used | free |
Passage Number | Unknown (11 at bank) | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | Confirmed as human by NP, G6PD, AST. |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | No | Exoteric Gene | |
Medium for Freezing | 10% DMSO, 20% FBS - culture medium | CO2 Conc. | 5% |
Viability immediately after thawing (%) | Additional information |
Cell No. | JCRB0156 | Cell Name | |
---|---|---|---|
LOT No. | 01212001 | Lot Specification | distribution |
Medium | RPMI1640 medium with 10% fetal bovine serum and 100 units/ml IL-2 (corresponds to 50 ng/ml IL-2 Wako#097-03951) | Temperature | 37 C |
Cell Density at Seeding | 2 x 10^5 cells/ml | Methods for Passages | dilution (avoid excessive dilution) |
Doubling Time | Cell Number in Vial (cells/1ml) | 2.7 x 10^6 | |
Viability at cell freezing (%) | 80.9 | Antibiotics Used | free |
Passage Number | P11* | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | Confirmed as human by NP, G6PD (type B), MD. |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | No | Exoteric Gene | |
Medium for Freezing | 10% DMSO, 20% FBS-base medium | CO2 Conc. | 5% |
Viability immediately after thawing (%) | Additional information |
Cell No. | JCRB0156 | Cell Name | KHYG-1 |
---|---|---|---|
LOT No. | 12092013 | Lot Specification | distribution |
Medium | RPMI1640 medium with 10% fetal bovine serum (GIBCO Cat. # 10091) and 100 units/mL recombinant human IL-2 (Pepro Tech; Cat. # 200-02) | Temperature | 37 C |
Cell Density at Seeding | 1.5 -3.0 x 10^5 cells/mL | Methods for Passages | Simple dilution. (avoid excessive dilution) |
Doubling Time | Cell Number in Vial (cells/1ml) | 4.3 x 10^6 | |
Viability at cell freezing (%) | 96.4 | Antibiotics Used | free |
Passage Number | Unknown (9 at bank) | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | Confirmed as human by NP, G6PD (type B), MD. |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | No | Exoteric Gene | |
Medium for Freezing | 10% DMSO, 20% FBS - culture medium | CO2 Conc. | 5% |
Viability immediately after thawing (%) | 96.4 | Additional information |
Cell No. | JCRB0156 | Cell Name | KHYG-1 |
---|---|---|---|
LOT No. | 11202015 | Lot Specification | distribution |
Medium | RPMI1640 medium with 10% heat-inactivated fetal bovine serum (GIBCO Cat. # 10091) and 100 units/ml of recombinant human IL-2 (Pepro Tech; Cat. # 200-02) | Temperature | 37 C |
Cell Density at Seeding | 3.7 - 5.7 x 10^5 cells/mL | Methods for Passages | Simple dilution (suspension culture). Avoid excessive dilution. |
Doubling Time | approx. 30 hrs. | Cell Number in Vial (cells/1ml) | 2.1 x 10^6 |
Viability at cell freezing (%) | 87 | Antibiotics Used | free |
Passage Number | Unknown (9 at bank) | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | D5S818:9,11 D13S317:9,13 D7S820:10,11 D16S539:9 VWA:17 TH01:6 AM:X TPOX:9,11 CSF1PO:12 |
|
Adhesion | No | Exoteric Gene | |
Medium for Freezing | 10% DMSO, 20% FBS - RPMI1640 | CO2 Conc. | 5% |
Viability immediately after thawing (%) | 87 | Additional information |
Cell No. | JCRB0156 | Cell Name | KHYG-1 |
---|---|---|---|
LOT No. | 10182016 | Lot Specification | distribution |
Medium | RPMI1640 medium with 10% fetal bovine serum (FBS; Sigma Cat. # 172012) and 100 units/ml recombinant human IL-2 (Pepro Tech; Cat. # 200-02) | Temperature | 37 C |
Cell Density at Seeding | approx. 1 x 10^5 cells/mL | Methods for Passages | Simple dilution (suspension culture). Subculture every 3-4 days with split ratio = 1/4. |
Doubling Time | approx. 25 hrs. | Cell Number in Vial (cells/1ml) | 2.9 x 10^6 |
Viability at cell freezing (%) | 85 | Antibiotics Used | free |
Passage Number | Unknown (9 at bank) | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | No | Exoteric Gene | |
Medium for Freezing | 10% DMSO, 20% FBS - RPMI1640 | CO2 Conc. | 5% |
Viability immediately after thawing (%) | 85 | Additional information |
Cell No. | JCRB0156 | Cell Name | KHYG-1 |
---|---|---|---|
LOT No. | 10192018 | Lot Specification | distribution |
Medium | RPMI 1640 medium with 10% fetal bovine serum (FBS; Sigma Cat. # 172012) and 100 units/mL recombinant human IL-2 (Pepro Tech; Cat. # 200-02) | Temperature | 37 C |
Cell Density at Seeding | approx. 1 x 10^5 cells/mL | Methods for Passages | Simple dilution (suspension culture). Subculture every 3-4 days with split ratio = 1/4. |
Doubling Time | approx. 27 hrs. | Cell Number in Vial (cells/1ml) | 9.6 x 10^5 |
Viability at cell freezing (%) | Antibiotics Used | free | |
Passage Number | Unknown (9 at bank) | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | No | Exoteric Gene | |
Medium for Freezing | 10% DMSO, 20% FBS - RPMI 1640 | CO2 Conc. | 5% |
Viability immediately after thawing (%) | 87.3 | Additional information |
Cell No. | JCRB0156 | Cell Name | KHYG-1 |
---|---|---|---|
LOT No. | 12072020 | Lot Specification | distribution |
Medium | RPMI1640 medium(GIBCO:Cat No.;11875-093) with 10% heat inactivated fetal bovine serum(SIGMA,Cat#172012,Lot#12J396) and IL-2(100 U/ml) (Pepro Tech,recombinant human IL-2) | Temperature | 37 C |
Cell Density at Seeding | 0.38-1.0x10^5 cells/ml | Methods for Passages | dilution |
Doubling Time | NT | Cell Number in Vial (cells/1ml) | 1.5x10^6 |
Viability at cell freezing (%) | 89.10 | Antibiotics Used | free |
Passage Number | p10* | PDL | NT |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | NT |
Chromosome Mode | NT | Chromosome Information | NT |
Surface Antigen | NT | DNA Profile (STR) | D5S818:9,11 D13S317:9,13 D7S820:10,11 D16S539:9 VWA:17 TH01:6 AM:X TPOX:9,11 CSF1PO:12 |
Adhesion | No | Exoteric Gene | NT |
Medium for Freezing | BAMBANKER(LYMPHOTEC Inc.,CS-02-001,NIPPON Genetics Co., LTD) | CO2 Conc. | 5% |
Viability immediately after thawing (%) | 72.70 | Additional information |
Images |
---|
Cell No. | JCRB0156 | Cell Name | KHYG-1 |
---|---|---|---|
LOT No. | 12212020 | Lot Specification | distribution |
Medium | RPMI 1640 medium with 10% fetal bovine serum (FBS; Sigma Cat. # 172012) and 100 units/mL recombinant human IL-2 (Pepro Tech; Cat. # 200-02) | Temperature | 37 C |
Cell Density at Seeding | 1 - 3 x 10^5 cells/mL | Methods for Passages | Simple dilution (suspension culture). Subculture every 3-4 days with split ratio = 1/4. |
Doubling Time | approx. 40 hrs. | Cell Number in Vial (cells/1ml) | 3.8 x 10^6 |
Viability at cell freezing (%) | Antibiotics Used | free | |
Passage Number | Unknown (18 at bank) | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | No | Exoteric Gene | |
Medium for Freezing | 10% DMSO, 20% FBS - RPMI1640 | CO2 Conc. | 5% |
Viability immediately after thawing (%) | 79 | Additional information |
Cell No. | JCRB0156 | Cell Name | KHYG-1 |
---|---|---|---|
LOT No. | 07292022 | Lot Specification | distribution |
Medium | RPMI 1640 medium with 10% fetal bovine serum (FBS; GIBCO Cat. # 10437) and 100 units/mL recombinant human IL-2 (Pepro Tech; Cat. # 200-02). Use 20% FBS at the intiation of culture. | Temperature | 37 C |
Cell Density at Seeding | 3 - 5 x 10^5 cells/mL | Methods for Passages | Simple dilution (suspension culture) |
Doubling Time | Cell Number in Vial (cells/1ml) | 6.6 x 10^5 | |
Viability at cell freezing (%) | Antibiotics Used | free | |
Passage Number | Unknown (12 at bank) | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | D5S818:9,11 D13S317:9,13 D7S820:10,11 D16S539:9 VWA:17 TH01:6 AM:X TPOX:9,11 CSF1PO:12 |
|
Adhesion | No | Exoteric Gene | |
Medium for Freezing | 5% DMSO, 20% FBS - RPMI1640 | CO2 Conc. | 5% |
Viability immediately after thawing (%) | 48.2 | Additional information | Many dead cells will appear immediately after thawing, but the growth and recovery after thawing was confirmed. |
Cell No. | JCRB0156 | Cell Name | KHYG-1 |
---|---|---|---|
LOT No. | 05222023 | Lot Specification | distribution |
Medium | RPMI 1640 medium with 10% fetal bovine serum (FBS; GIBCO Cat. # 10437) and 100 units/mL recombinant human IL-2 (Pepro Tech; Cat. # 200-02). Use 20% FBS at the intiation of culture. | Temperature | 37 C |
Cell Density at Seeding | 1.2 - 2.4 x 10^5 cells/mL | Methods for Passages | Simple dilution (suspension culture) |
Doubling Time | approx. 33 hrs. | Cell Number in Vial (cells/1ml) | 4.1 x 10^6 |
Viability at cell freezing (%) | 83 | Antibiotics Used | free |
Passage Number | Unknown (10 at bank) | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | No | Exoteric Gene | |
Medium for Freezing | 10% DMSO, 20% FBS - RPMI1640 | CO2 Conc. | 5% |
Viability immediately after thawing (%) | 78 | Additional information |